Noura S. Abul-Husn
Icahn School of Medicine at Mount Sinai
114 Papers
314 Citations
Noura S. Abul-Husn is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 25, co-authored 68 publications. Previous affiliations of Noura S. Abul-Husn include Queen's University & Regeneron.
Chat about Author
Papers
Towards a fine-scale population health monitoring system
Gillian M. Belbin,Stephane Wenric,Sinead Cullina,Benjamin S. Glicksberg,Arden Moscati,Genevieve L. Wojcik,Ruhollah Shemirani,Noam D. Beckmann,Ariella Cohain,Elena P. Sorokin,Danny S. Park,Danny S. Park,José Luis Ambite,Steve Ellis,Adam Auton,Cbipm Genomics Team,Erwin P. Bottinger,Judy H. Cho,Ruth J. F. Loos,Noura S. Abul-Husn,Noah Zaitlen,Christopher R. Gignoux,Eimear E. Kenny +22 more
TL;DR: In this article, a framework for repurposing data from Electronic Health Records (EHRs) in concert with genomic data to explore enrichment of disease within sub-populations was proposed.
Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.
A. Owusu Obeng,A. Owusu Obeng,Tom Kaszemacher,Noura S. Abul-Husn,Omri Gottesman,Aida Vega,Eva Waite,Kristin Myers,Judy H. Cho,Erwin P. Bottinger,Steve Ellis,Stuart A. Scott +11 more
TL;DR: A strategy that accounts for the complexity of race and leverages electronic health records for algorithm variables and deploying point‐of‐care dose recommendations is developed to facilitate multiethnic algorithm‐guided warfarin dosing using preemptive genetic testing.
GUÍA: a digital platform to facilitate result disclosure in genetic counseling
Sabrina A. Suckiel,Jaqueline A. Odgis,Katie Gallagher,Jessica E. Rodriguez,Dana Watnick,Gabrielle Bertier,Monisha Sebastin,Nicole M. Yelton,Estefany Maria,Jessenia Lopez,Michelle A. Ramos,Nicole Kelly,Nehama Teitelman,Faygel Beren,Tom Kaszemacher,Kojo Davis,Irma Laguerre,Lynne D. Richardson,George A. Diaz,Nathaniel M. Pearson,Stephen B. Ellis,Christian Stolte,Mimsie Robinson,Patricia Kovatch,Carol R. Horowitz,Bruce D. Gelb,John M. Greally,Laurie J. Bauman,Randi E. Zinberg,Noura S. Abul-Husn,Melissa P. Wasserstein,Eimear E. Kenny +31 more
TL;DR: GUIA communicates complex genomic information in an understandable and personalized manner and findings from the NYCKidSeq clinical trial will provide insight into GUIA's effectiveness in communicating results among diverse, multilingual populations.
Lynch Syndrome–Associated Variants and Cancer Rates in an Ancestrally Diverse Biobank
Rachel Rosenblum,Celina Ang,Sabrina A. Suckiel,Emily R. Soper,Meenakshi R Sigireddi,Sinead Cullina,Gillian M. Belbin,Aimee L. Lucas,Eimear E. Kenny,Noura S. Abul-Husn +9 more
- 23 Nov 2020
TL;DR: Although cancer risk is significantly increased among variant-positive individuals, the majority do not harbor a clinical diagnosis of LS, suggesting underrecognition of this disease.
13
Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis.
Emily R. Soper,Sabrina A. Suckiel,Giovanna T. Braganza,Amy R Kontorovich,Eimear E. Kenny,Noura S. Abul-Husn +5 more
TL;DR: The TTR V142I variant associated with hereditary transthyretin amyloidosis (hATTR) is present in up to 4% of African American and 1% of Hispanic/Latinx individuals and increases risk for heart failure as mentioned in this paper.
13